[{"Assets_0_Q3_USD":"1222500000.0","CIK":"1737287","CommonStockSharesIssued_0_Q3_shares":"139755839.0","CommonStockSharesOutstanding_0_Q3_shares":"139755839.0","Country":"United States","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"1134878416.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"-105118000.0","NetIncomeLoss_1_Q3_USD":"-66197000.0","NetIncomeLoss_3_Q3_USD":"-181651000.0","OfficialName":"Allogene Therapeutics Inc. Common Stock","ProfitLoss_3_Q3_USD":"-181651000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q3_USD":"1118731000.0","Ticker":"ALLO","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":"127140755.0","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":"117227079.0","filed":"20201104","footnote":null,"form":"10-Q","fp":"Q3","fy":"2020.0","name":"ALLOGENE THERAPEUTICS, INC.","period":"20200930","qtrs":"3","uom":"USD"}]